Influence of silibinin and β-β-dimethylacrylshikonin on chordoma cells

Influence of silibinin and β-β-dimethylacrylshikonin on chordoma cells


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: زهره جهان افروز

کلمات کلیدی: Chordoma, β-β-dimethylacrylshikonin, Silibinin, Apoptosis

نشریه: 27532 , 6 , 49 , 2018

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله زهره جهان افروز
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات ایمونولوژی
کد مقاله 63652
عنوان فارسی مقاله Influence of silibinin and β-β-dimethylacrylshikonin on chordoma cells
عنوان لاتین مقاله Influence of silibinin and β-β-dimethylacrylshikonin on chordoma cells
ناشر 10
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ خیر
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Background: Chordoma, slow growing bone tumours originating from remnants of the notochord, leave affected patients with a median survival of six years. The high recurrence rate of chordoma, together with limited treatment options and bad overall prognosis, make the development of new treatment options urgently necessary. Purpose: In this study, the potential of two natural products, silibinin and β-β- dimethylacrylshikonin (DMAS), was tested on clival (MUG-CC1 and UM-Chor1) as well as sacral (MUG-Chor1 and U-CH2) chordoma cell lines. The treatment was administered both as single- and combined therapy. Methods: For investigation of cell viability, the Cell Titer 96 Aqueous Non-Radioactive Cell Proliferation Assay Kit was used. Apoptosis induction was studied by flow cytometry, (Annexin V/SYTOX Green, caspase-3) and RT-qPCR. Pathway analyses were performed by western blot. Results: Both drugs were found to reduce cell viability alone as well as in combination in a dose dependent manner, with DMAS being more efficient than silibinin. The mode of cell death was mainly apoptosis in DMAS treated samples, while the combination therapy led to apoptosis as well as late-apoptosis/necrosis. Silibinin therapy alone, although reducing cell viability, did not lead to significant apoptotic effects in the performed assays. Focussing on the molecular mechanism of DMAS induced apoptosis, it was found that major genes of the mitochondrial apoptosis pathway, like NOXA and PUMA were overexpressed. Additionally, western blot experiments showed a decrease of ERK/pERK, STAT3/pSTAT3 (Tyr705) and AKT/pAKT expression/activation levels under DMAS treatment. Conclusion: DMAS is a promising new candidate for chordoma therapy, while silibinin or a combination of both is less favourable.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
زهره جهان افروزاول

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
Influence of silibinin and dmas on chordoma cells.pdf1397/07/172734403دانلود